Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients – 30 months follow‐up
Trine‐Lise Larsen, Herish Garresori, Jorunn Brekke, Tone Enden, Hege Frøen, E. Jacobsen, Petter Quist‐Paulsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Osvik Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders Erik Astrup Dahm
Topics & Concepts
ApixabanMedicineVenous thromboembolismSecondary prophylaxisCancerSecondary preventionInternal medicineSurgeryRivaroxabanWarfarinThrombosisAtrial fibrillationVenous Thromboembolism Diagnosis and ManagementAtrial Fibrillation Management and OutcomesAntiplatelet Therapy and Cardiovascular Diseases